The activation of TGFB signaling depresses the biological activity of cytotoxic T-lymphocytes and natural killer cells by promoting the proliferation of regulatory T-cells (Tregs) and cancer-associated fibroblasts (CAFs), thus creating an immunosuppressive TME34. Here, TGFB1 is linked to cancer.